177 related articles for article (PubMed ID: 28090686)
1. Effectively enhancing cytotoxic and apoptotic effects of alpha-momorcharin by integrating a heparin-binding peptide.
Tan MJ; Cao XW; Li PF; Zhai YZ; Zhou Y; Liu YJ; Zhao J; Wang FJ
Biotechnol Appl Biochem; 2017 Nov; 64(6):918-926. PubMed ID: 28090686
[TBL] [Abstract][Full Text] [Related]
2. The heparin-binding domain of HB-EGF as an efficient cell-penetrating peptide for drug delivery.
Luo Z; Cao XW; Li C; Wu MD; Yang XZ; Zhao J; Wang FJ
J Pept Sci; 2016 Nov; 22(11-12):689-699. PubMed ID: 27739168
[TBL] [Abstract][Full Text] [Related]
3. Alpha-momorcharin (α-MMC) exerts effective anti-human breast tumor activities but has a narrow therapeutic window in vivo.
Cao D; Sun Y; Wang L; He Q; Zheng J; Deng F; Deng S; Chang S; Yu X; Li M; Meng Y; Jin J; Shen F
Fitoterapia; 2015 Jan; 100():139-49. PubMed ID: 25447153
[TBL] [Abstract][Full Text] [Related]
4. Preferential cytotoxicity of the type I ribosome inactivating protein alpha-momorcharin on human nasopharyngeal carcinoma cells under normoxia and hypoxia.
Pan WL; Wong JH; Fang EF; Chan YS; Ng TB; Cheung RC
Biochem Pharmacol; 2014 Jun; 89(3):329-39. PubMed ID: 24637239
[TBL] [Abstract][Full Text] [Related]
5. Preparation of an antitumor and antivirus agent: chemical modification of α-MMC and MAP30 from Momordica Charantia L. with covalent conjugation of polyethyelene glycol.
Meng Y; Liu S; Li J; Meng Y; Zhao X
Int J Nanomedicine; 2012; 7():3133-42. PubMed ID: 22802682
[TBL] [Abstract][Full Text] [Related]
6. PEGylation alleviates the non-specific toxicities of Alpha-Momorcharin and preserves its antitumor efficacy in vivo.
Deng NH; Wang L; He QC; Zheng JC; Meng Y; Meng YF; Zhang CJ; Shen FB
Drug Deliv; 2016; 23(1):95-100. PubMed ID: 24786488
[TBL] [Abstract][Full Text] [Related]
7. Alpha-momorcharin regulates cytokine expression and induces apoptosis in monocytes.
Deng N; Sun Y; Liu M; He Q; Wang L; Zhang Y; Sun W; Lei N; Liu Y; Luo Y; Shen F
Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):258-266. PubMed ID: 31062632
[No Abstract] [Full Text] [Related]
8. PEGylation is effective in reducing immunogenicity, immunotoxicity, and hepatotoxicity of α-momorcharin in vivo.
Zheng JC; Lei N; He QC; Hu W; Jin JG; Meng Y; Deng NH; Meng YF; Zhang CJ; Shen FB
Immunopharmacol Immunotoxicol; 2012 Oct; 34(5):866-73. PubMed ID: 22439816
[TBL] [Abstract][Full Text] [Related]
9. A novel trichosanthin fusion protein with increased cytotoxicity to tumor cells.
Lin B; Yang XZ; Cao XW; Zhang TZ; Wang FJ; Zhao J
Biotechnol Lett; 2017 Jan; 39(1):71-78. PubMed ID: 27714558
[TBL] [Abstract][Full Text] [Related]
10. Α-MMC and MAP30, two ribosome-inactivating proteins extracted from Momordica charantia, induce cell cycle arrest and apoptosis in A549 human lung carcinoma cells.
Fan X; He L; Meng Y; Li G; Li L; Meng Y
Mol Med Rep; 2015 May; 11(5):3553-8. PubMed ID: 25573293
[TBL] [Abstract][Full Text] [Related]
11. Ribosome-Inactivating Protein α-Momorcharin Derived from Edible Plant
Chen YJ; Zhu JQ; Fu XQ; Su T; Li T; Guo H; Zhu PL; Lee SK; Yu H; Tse AK; Yu ZL
Toxins (Basel); 2019 Nov; 11(12):. PubMed ID: 31779275
[TBL] [Abstract][Full Text] [Related]
12. Screening and characterization of a novel high-efficiency tumor-homing cell-penetrating peptide from the buffalo cathelicidin family.
Xu YY; Cao XW; Fu LY; Zhang TZ; Wang FJ; Zhao J
J Pept Sci; 2019 Sep; 25(9):e3201. PubMed ID: 31309656
[TBL] [Abstract][Full Text] [Related]
13. Heparin-binding protein targeted to mitochondrial compartments protects endothelial cells from apoptosis.
Olofsson AM; Vestberg M; Herwald H; Rygaard J; David G; Arfors KE; Linde V; Flodgaard H; Dedio J; Müller-Esterl W; Lundgren-Akerlund E
J Clin Invest; 1999 Oct; 104(7):885-94. PubMed ID: 10510329
[TBL] [Abstract][Full Text] [Related]
14. Effect of α, β momorcharin on viability, caspase activity, cytochrome c release and on cytosolic calcium levels in different cancer cell lines.
Manoharan G; Jaiswal SR; Singh J
Mol Cell Biochem; 2014 Mar; 388(1-2):233-40. PubMed ID: 24297707
[TBL] [Abstract][Full Text] [Related]
15. Enhancing tumor-specific intracellular delivering efficiency of cell-penetrating peptide by fusion with a peptide targeting to EGFR.
Nguyen LT; Yang XZ; Du X; Wang JW; Zhang R; Zhao J; Wang FJ; Dong Y; Li PF
Amino Acids; 2015 May; 47(5):997-1006. PubMed ID: 25655386
[TBL] [Abstract][Full Text] [Related]
16. Alpha-Momorcharin, a type I ribosome inactivating protein, induced apoptosis of hepatocellular carcinoma SK-HEP-1 cells through mitochondrial pathway.
Yang D; Peng D; Zhou Y; Qiang Z; Wan L; Fan X; Meng Y; Xu G; Meng Y
Nat Prod Res; 2023 Dec; ():1-11. PubMed ID: 38126176
[TBL] [Abstract][Full Text] [Related]
17. Isobavachalcone isolated from
Li Y; Qin X; Li P; Zhang H; Lin T; Miao Z; Ma S
Drug Des Devel Ther; 2019; 13():1449-1460. PubMed ID: 31118579
[No Abstract] [Full Text] [Related]
18. Enhanced anti-tumor activity of trichosanthin after combination with a human-derived cell-penetrating peptide, and a possible mechanism of activity.
Lu YZ; Li PF; Li YZ; Luo F; Guo C; Lin B; Cao XW; Zhao J; Wang FJ
Fitoterapia; 2016 Jul; 112():183-90. PubMed ID: 27050721
[TBL] [Abstract][Full Text] [Related]
19. Identifying the functional part of heparin-binding protein (HBP) as a monocyte stimulator and the novel role of monocytes as HBP producers.
Schou M; Djurup R; Norris K; Flodgaard H
Innate Immun; 2011 Feb; 17(1):60-9. PubMed ID: 20083497
[TBL] [Abstract][Full Text] [Related]
20. Basic residues in azurocidin/HBP contribute to both heparin binding and antimicrobial activity.
McCabe D; Cukierman T; Gabay JE
J Biol Chem; 2002 Jul; 277(30):27477-88. PubMed ID: 11994286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
